Unadkat, Prashin
Quevedo, Joao
Soares, Jair
Fenoy, Albert
Funding for this research was provided by:
NIH/NIMH (1R21MH117636-01A1)
Faillace Department of Psychiatry and Behavioral Sciences
LivaNova
Bristol-Meyers Squibb
Forest Laboratories
Merck and Elan Pharmaceuticals
NIH/NINDS (1R01NS113893-01A1)
Article History
Received: 11 September 2023
Accepted: 8 March 2024
First Online: 14 March 2024
Declarations
:
: AJF serves as a consultant for Medtronic, Inc and receives grant support from the NIH/NINDS (1R01NS113893-01A1). JQ receives research support from the NIH/NIMH (1R21MH117636-01A1), the Faillace Department of Psychiatry and Behavioral Sciences, and LivaNova; has speaker bureau membership with Myriad Neuroscience, Janssen Pharmaceuticals, and Abbvie; is consultant for Eurofarma; is stockholder at Instituto de Neurociencias Dr. Joao Quevedo; and receives copyrights from Artmed Editora, Artmed Panamericana, and Elsevier/Academic Press. JCS receives grant/research support from Bristol-Meyers Squibb, Forest Laboratories, Merck and Elan Pharmaceuticals, and serves as a consultant for Pfizer, Abbot, and Astellas Pharma, Inc. PU reported no biomedical financial interests or potential conflicts of interest.